Walkthrough of a Powerful Bioinformatics Platform for End-to-End RNA-Seq Analysis
RNA-sequencing (RNA-seq) helps biopharma groups explore the intricate landscape of gene expression, unravel disease mechanisms, discover biomarkers, and propel the development of innovative therapies. However, the sheer volume and complexity of transcriptomic information often overwhelms teams, creating barriers to collaboration and causing procedural bottlenecks that delay discoveries and insights. DNAnexus provides a streamlined solution for the ingestion, analysis, visualization, and interpretation of omics data. We arm users with out-of-the-box tools and capabilities and an intuitive user interface, allowing them to easily interrogate their data, integrate with their tech stack, and collaborate internally and externally without compromising data security or regulatory compliance.
Watch on demand as our experts demonstrate how DNAnexus can help your organization efficiently tackle the analysis of RNA-seq data with DNAnexus. They will also cover the power of DNAnexus partnerships, demonstrating how the Omics Playground, an interactive data analysis and data viz platform provided by BigOmics, can be used as part of an end-to-end data workflow within the DNAnexus platform.
At DNAnexus, Dr. Billaud helps to promote omics-adapted bioinformatics pipelines that serve the scientific community for getting faster molecular insights. Before joining DNAnexus, Dr. Billaud was Senior Principal Scientist at QIAGEN Digital Insights and collaborated on numerous research program in oncology, infectious diseases. Dr. Billaud holds a Master of Sciences in Molecular and Cellular Biology from University Pierre et Marie Curie Paris VI (France) and a Ph.D. in Blood Cell Biology from University Paris VII (France) and he did his post-doctoral work at the Scripps Research Institute (San Diego, CA).
Matthew Andreatta, Ph.D., serves as a Solutions Science Director for DNAnexus helping Diagnostic companies, Pharmaceutical partners, and Data Providers glean actionable insights from multiomic and clinical information. He’s spent the last 9 years building tools and visualizations to explore health-related genomic datasets that support patient-driven decisions and analytic workflows. Matthew holds a Bachelor of Science in Biotechnology from University of California at Davis, a Master’s of Science in Molecular Biology from Purdue University, and a Ph.D. in Genomics from Purdue University.
